![]() | ![]() |
Formats:
|
||||||||||||
Copyright © 2005, The National Academy of Sciences Developmental Biology Drosophila microRNAs exhibit diverse spatial expression patterns during embryonic development Department of Molecular and Cell Biology, and Howard Hughes Medical Institute, University of California, Berkeley, CA 94720-3200 † To whom correspondence may be addressed. E-mail: gerry/at/fruitfly.berkeley.edu or laie/at/mskcc.org. *Present address: Max Planck Institute of Molecular Cell Biology and Genetics, Pfotenhauerstrasse 108, D-01307 Dresden, Germany. ‡Present address: Department of Developmental Biology, Memorial Sloan-Kettering Cancer Center, Box 252, 1275 York Avenue, New York, NY 10021. Contributed by Gerald M. Rubin, October 7, 2005 Freely available online through the PNAS open access option. This article has been cited by other articles in PMC.Abstract MicroRNAs (miRNAs) are an extensive class of regulatory RNA whose specific functions in animals are generally unknown. Although computational methods have identified many potential targets of miRNAs, elucidating the spatial expression patterns of miRNAs is necessary to identify the sites of miRNA action. Here, we report the spatial patterns of miRNA transcription during Drosophila embryonic development, as revealed by in situ hybridization to nascent miRNA transcripts. We detect expression of 15 “stand-alone” miRNA loci and 9 intronic miRNA loci, which collectively represent 38 miRNA genes. We observe great variety in the spatial patterns of miRNA transcription, including preblastoderm stripes, in aspects of the central and peripheral nervous systems, and in cellular subsets of the mesoderm and endoderm. We also describe an intronic miRNA (miR-7) whose expression pattern is distinct from that of its host mRNA (bancal), which demonstrates that intronic miRNAs can be subject to independent cis-regulatory control. Intriguingly, the expression patterns of several fly miRNAs are analogous to those of their vertebrate counterparts, suggesting that these miRNAs may have ancient roles in animal patterning. Keywords: in situ hybridization, nascent transcript Since the realization in late 2001 that microRNAs (miRNAs) comprise a substantial gene family in diverse eukaryotes, miRNAs have been the subject of intense study (1, 2). miRNAs are 21- to 24-nt RNAs that form duplexes with target mRNA transcripts and induce transcript cleavage and/or inhibit productive translation. The identification of plant miRNA targets was enabled by the general observation of near-perfect complementarities between miRNAs and their targets (3). Animal miRNA target identification has been greatly hindered by the limited complementarity between animal miRNAs and their targets. The recent availability of many additional animal genome sequences has greatly improved target predictions; nevertheless, few coherent hypotheses as to the specific biological functions of individual miRNAs have come solely from bioinformatics. Knowledge of tissue-specific and cell-specific expression patterns of miRNAs can directly inform functional studies. For example, murine miR-181 was isolated on the basis of its predominant expression in the thymus and proved to regulate cell fate choice in the hematopoietic lineage (4). miR-375 is specifically expressed in pancreatic islet cells, where it regulates genes involved in insulin secretion (5). miR-1 is found exclusively in muscles, where it regulates cardiomyocyte proliferation in vertebrates (6) and muscle physiology in flies (7). Finally, the worm miRNAs lsy-6 and miR-273 are asymmetrically expressed in the pair of ASE neurons, and they control the identity of these two neurons by inhibiting different transcription factors that regulate ASE left/right cell fate (8, 9). Although temporal expression of miRNAs can be assessed by Northern analysis, methods to analyze their spatial expression have been limited. The strategy most widely used has been Northern analysis using RNA from dissected vertebrate organs (10). However, this process provides coarse spatial and cell type resolution as most organs have many cell types, which may or may not all express a given miRNA. An alternative strategy involves a “miRNA sensor,” a ubiquitously expressed transgene containing perfectly complementary binding sites for the miRNA. The miRNA sensor is a substrate for miRNA-directed destruction via the RNA interference pathway (11), and its expression will thus be lower in regions of high miRNA activity. This approach has succeeded for a few fly and murine miRNAs (12, 13). Nevertheless, utilization of this technique has been limited thus far, perhaps because perdurance of the reporter at the protein level masks the activity of dynamically expressed miRNAs. For these reasons, methods to directly visualize miRNAs in situ are desirable. RNA probes antisense to the pre-miRNA transcript or mature miRNA itself have not proven effective, perhaps because of the stable duplex nature of the former or the limited hybridization potential to the latter. Inspired by the finding that pre-miRNAs derive from longer primary transcripts (14), we examined whether nascent miRNA transcripts could be detected with antisense probe-derived genomic DNA surrounding pre-miRNA hairpins. This strategy was recently shown to detect nascent miRNA transcripts in Drosophila embryos (15, 16). In these studies, miRNA transcription was detected as pairs of nuclear dots, which correspond to sites of transcriptional activity. We used this strategy to examine expression of Drosophila miRNAs during embryonic development and found that miRNAs display diverse and dynamic expression patterns. The expression of some miRNAs is modulated along the anterior-posterior or dorsal-ventral axes early in development, others are activated in specific germ layers, and still others are present in specific organs or differentiating cells. Interestingly, the tissue specificity of several miRNAs conserved between vertebrates and flies has been conserved, suggesting ancient roles for these genes in developmental patterning and/or organ function. These data identify specific tissues and cells as sites for regulation by miRNAs, knowledge that will inform functional studies. Materials and Methods Probe Design. We generated ≈1-kb templates, with T7 promoters appended to the antisense strand, from all known Drosophila miRNA loci. In most cases, the pre-miRNA hairpin resides in the center of this probe, although the probe window was shifted to avoid overlap with Drosophila genome 3.1 mRNA annotations. Where multiple miRNAs reside in a cluster, we designed one probe that spans the cluster and nonoverlapping subcluster probes. For intronic miRNAs, we attempted to minimize or exclude overlap with host gene exons, with the provision that probes be at least 500 bp in length. In Situ Hybridization. Antisense digoxigenin-labeled probes were produced by using the above templates and T7 polymerase. Embryos were fixed and prepared by using standard protocols (17), with the modification that Proteinase K was omitted in favor of a 30-min wash in 0.5% SDS. Embryos were prehybridized for 6–8 h and then hybridized in 0.1 ng/μl probe for 24 h at 60°C. Results Detection of Primary miRNA Transcripts. Whole-mount in situ hybridization has long been a powerful technique for visualizing gene expression in Drosophila (17). Although a number of transcripts with subcellular localization have been described, typical mRNAs are predominantly observed in the cytoplasm (Fig. 1A
We generated ≈1-kb digoxigenin-labeled antisense probes to all known Drosophila miRNA loci (as detailed in Materials and Methods) and hybridized them to 0- to 16-h embryos. Probes to almost half of the miRNA loci gave spatially/temporally modulated patterns, including both intronic miRNAs and “stand-alone” loci (Fig. 2
One advantage of analyzing nascent transcription is its ability to distinguish among closely related miRNAs that cannot be discriminated with Northern analysis. For example, there are four Drosophila loci that collectively encode eight nearly identical members of the miR-2/miR-13 family. We detected spatially distinct expression for three of these loci: the stand-alone miRNA cluster miR-13b-1/13a/2c is restricted to the central nervous system (Fig. 2L Notably, we detected specific expression of the Drosophila ortholog of vertebrate miR-375 (5) in salivary glands and hindgut (Fig. 2N Altogether, we observed spatially patterned expression of miRNAs from the initiation of zygotic transcription, with a variety of patterns later observed in all three germ layers and in an assortment of differentiating organs. An overview of these miRNA expression patterns is shown in Fig. 2 Early Embryonic Expression of miRNAs Is Modulated Along the Anterior-Posterior Axis. Early embryonic development in Drosophila is directed by a hierarchy of gene activities that progressively subdivide regions of the embryo along the anterior-posterior axis. Several miRNAs are also expressed in patterns that suggest a role in this process. The miRNAs of the miR-309/3/286/4/5/6 cluster are initially expressed broadly, but become repressed terminally and in the vicinity of the presumptive head (Fig. 2 A
The two known miRNAs of the Drosophila Hox clusters, miR-10 and iab-4, also show Hox-like expression that reflects their relative proximal-distal position within the Hox complexes (Fig. 2 B and C miR-274, a rare intronic miRNA that is oriented antisense to its host gene (CG 32085), is expressed predominantly in a single anterior stripe in blastoderm embryos roughly corresponding to the intercalary segment (Fig. 2P Expression of miRNAs in the Mesoderm and Mesodermally Derived Tissues. Gene expression is often initiated in statu nascendi, that is, in spatial regions that prefigure tissue differentiation (22). A striking example of this type of expression pattern is seen with miR-1, which is expressed throughout the presumptive trunk and head mesoderm before gastrulation, with a gap at the position of the future anterior endoderm (Fig. 3L Several other stand-alone miRNAs are expressed in the mesoderm, including miR-316, miR-8, and miR-184 (Fig. 2 F–H Expression of miRNAs in the Neural Ectoderm and Differentiating Nervous System. Many vertebrate miRNAs are enriched in the nervous system (23, 24), which is consistent with the complexity of neural cell identities and the exceptional needs of neurons for translational regulation. As shown in Fig. 2 Differntial Expression of an Intronic miRNA and Its Host Gene. Microarray analysis showed that intronic miRNA expression profiles are highly correlated with those of their hosts (25). Discrepancies between the expression profiles of miRNAs and host genes were attributed to the existence of miRNA paralogs whose potentially distinct expression was not distinguished by the array protocol. In our in situ hybridization studies, we found that many intronic miRNA probes gave patterns indistinguishable from probes synthesized from host gene cDNAs. However, miR-7 provides an interesting counterexample (Fig. 4
Drosophila miR-7 resides in a 3′ intron of bancal/heterogeneous nuclear ribonucleoprotein K (hnRNP-K) (26). The observation that one of the vertebrate miR-7 genes similarly resides in an intron of hnRNP-K suggested an intimate functional association between them. However, in vivo analyses demonstrate that key miR-7 targets include Hairy/E(spl)bHLH repressor genes and Bearded family genes (19, 27). These genes function in segmentation, sensory organ development, and Notch signal transduction and are not ostensibly linked to hnRNP-K function. bancal was previously reported to be ubiquitously expressed (28), which we verified by using a probe to a bancal 5′ exon (Fig. 4F P-elements preferentially insert in promoters and gene 5′ regions. Curiously then, there are two clusters of P-element insertions in the bancal locus, one in the 5′ region of bancal and a second cluster in a very 3′ intron (31). A set of cDNAs that initiate in the vicinity of these downstream P insertions have been isolated that correspond to a putative internal promoter for the bancal-RD isoform (Fig. 4A Discussion Spatially Discrete Patterns of miRNA Deployment. We have shown that detection of miRNA transcription in situ can be achieved with probes that overlap primary miRNA transcripts. An important conclusion of this work is a biologically informed viewpoint as to the endogenous functions of miRNAs. Our detection of a diverse set of miRNA expression patterns implicates specific aspects of developmental patterning as subject to regulation by miRNAs. For example, neural-specific miRNAs and muscle-specific miRNAs identified in this study are likely to function in the development and/or physiology of the nervous system and musculature, respectively. Integration of these expression data with computational predictions of miRNA targets (27, 32, 33) will drive hypothesis-based functional studies of these miRNAs. We failed to detect expression for several miRNA loci whose presence in embryos is known from Northern analysis (34, 35). These include the miR-310/311/312/313 cluster, the miR-275/305 cluster, the miR-9c/79/9b/306 cluster, miR-287, miR-33, and bantam. Although we cannot rule out a technical basis for failure to detect them, it is evident from Northern analysis that many of these miRNAs are maternally deposited (34, 35). If these loci are exclusively maternally inherited, and are not actively transcribed zygotically, then maternal deposition might explain a lack of nascent transcripts in the embryo. Alternatively, the primary miRNA transcripts may be too short or processed too rapidly to be detected by this method. Another caveat to these expression data are that nascent transcription may not precisely parallel the accumulation of mature miRNAs. For example, it should take a certain amount of time for the nascent transcript to be processed into a pre-miRNA hairpin by Drosha, exported to the cytoplasm, and then processed by Dicer. If any of these steps happens to be regulated that could further delay the appearance of mature miRNAs relative to one's ability to detect nascent transcripts. For these reasons, detection of mature miRNAs would also be desirable. While this manuscript was in preparation, Plasterk and colleagues (30) presented an analysis of mature miRNA expression patterns during zebrafish development using locked nucleic acid (LNA) oligonucleotide probes. In this case, miRNA expression was detected in the cytoplasm but not the nucleus, suggesting that these probes primarily report on the expression of pre-miRNAs or mature miRNAs. Sokol and Ambros (7) have also successfully detected Drosophila miR-1 in embryos by using an LNA probe, suggesting that this technique may provide a powerful complementary method for miRNA detection. An intriguing finding of the zebrafish study was that whereas diverse patterns of expression in later stages was seen, there was a general absence of miRNAs during early development (30). Therefore, miRNAs may be preferentially required during differentiation or maintenance of cell or tissue identity. In support of this idea, maternal+zygotic Dicer mutant zebrafish embryos, which lack miRNAs entirely, show minor defects through early development and cell/tissue specification, but later display profound abnormalities during morphogenesis (36). In contrast, we observe that patterned expression of many Drosophila miRNAs at the onset of zygotic transcription in early embryos. Moreover, additional miRNAs are maternally deposited (whose nascent expression we did not observe), which may help set an early landscape of gene regulation (34). We infer from this finding that miRNAs regulate regional identity and early tissue specification in Drosophila. It remains to be determined whether miRNAs in other animal species are more fish-like or fly-like in this regard. However, the fact that Dicer-mutant mouse embryos arrest at a very early stage strongly suggests essential early roles for miRNAs in mammals (37). miRNA Expression Patterns Correlate with miRNA Functions. The catalog of miRNA expression patterns described here provides a sensible basis for generating specific hypotheses regarding specific developmental settings that are under miRNA control. In a recent study, injected 2′ O-methylated oligonucleotides (2′Ome oligos) antisense to miRNAs were used to titrate miRNA function in Drosophila embryos (35). We observe several correlations between the tissues affected in this screen with expression patterns determined in this study. This correlation is particularly evident with miRNAs that are expressed in, and are required for, normal development of the nervous system. For example, 2′Ome oligos against miR-315, miR-279, and members of the miR-12/283/304 cluster all induced nervous system defects, and all of them are indeed specifically expressed in aspects of the embryonic peripheral or central nervous system. The knowledge of the spatial expression of these other Drosophila miRNAs permits more directed tests of cell fate specification and differentiation. For example, Leaman et al. (35) reported that 2′O-methyl oligoribonucleotide against miR-1 resulted in embryos that were generally “scrambled.” However, the specific and persistent expression of miR-1 throughout the mesoderm and differentiating visceral and cardiac musculature instead suggests a primary defect in muscle development and/or function. Indeed, using a deletion allele of miR-1, Sokol and Ambros (7) have recently shown that Drosophila miR-1 is required for normal muscle physiology. Evidence for Conservation of miRNA Function Independent of Predicted Targets. Many miRNAs are highly conserved between invertebrates and vertebrates, which might indicate that their functions have been conserved. Nevertheless, few examples exist of highly conserved miRNA–target interactions. In this study, we observed that the tissue specificity of several highly conserved miRNAs has been conserved among flies, fish, and mammals. For example, we infer ancient roles for miR-1 in mesoderm and muscles, for miR-124 and miR-7 in the nervous system, and for miR-10 in anterior-posterior identity. There are several ways by which conserved activity of a miRNA might manifest itself. In a more conventional way of thinking, key individual targets may be bound by essential regulatory relationships. This phenomenon appears to be the rule in plants, but may, for example, apply to potentially conserved let-7 sites in vertebrate orthologs of lin-28 (38). In an alternate scenario, the likely existence of multiple targets for each miRNA might maintain selective pressure on the miRNA sequence, but still permit drift in the portfolio of transcripts regulated by each miRNA. Nevertheless, fixed miRNA expression in, say, the nervous system or muscles, might constrain the type of targets controlled by an individual miRNA. In this case, miRNAs would not act as specific gene switches but more as global regulators of tissue identity, as recently suggested by Lim and colleagues (39) for miR-1 and miR-124. We expect that integration of miRNA expression data with bioinformatic predictions will permit accelerated progress in understanding the biological processes controlled by animal miRNAs. Acknowledgments We thank Amy Beaton for expert help with imaging and annotation. This work was supported by the Howard Hughes Medical Institute. A.A.A. is funded by the Wellcome Trust International Research Foundation. E.C.L. is supported by fellowships from the Leukemia and Lymphoma Society and the Burroughs Wellcome Foundation. Notes Author contributions: A.A.A., P.T., and E.C.L. designed research; A.A.A. and E.C.L. performed research; A.A.A. and P.T. contributed new reagents/analytic tools; A.A.A., P.T., N.P., G.M.R., and E.C.L. analyzed data; and E.C.L. wrote the paper. Conflict of interest statement: No conflicts declared. Abbreviation: miRNA, microRNA. References 1. Bartel, D. P. (2004. ) Cell 116, 281–297. [PubMed] 2. Lai, E. C. (2003. ) Curr. Biol. 13, R925–R936. [PubMed] 3. Rhoades, M. W., Reinhart, B. J., Lim, L. P., Burge, C. B., Bartel, B. & Bartel, D. P. (2002. ) Cell 110, 513–520. [PubMed] 4. Chen, C. Z., Li, L., Lodish, H. F. & Bartel, D. P. (2004. ) Science 303, 83–86. [PubMed] 5. Poy, M. N., Eliasson, L., Krutzfeldt, J., Kuwajima, S., Ma, X., Macdonald, P. E., Pfeffer, S., Tuschl, T., Rajewsky, N., Rorsman, P. & Stoffel, M. (2004. ) Nature 432, 226–230. [PubMed] 6. Zhao, Y., Samal, E. & Srivastava, D. (2005. ) Nature 436, 219–220. 7. Sokol, N. S. & Ambros, V. (2005. ) Genes Dev. 19, 2343–2354. [PubMed] 8. Chang, S., Johnston, R. J., Jr., Frokjaer-Jensen, C., Lockery, S. & Hobert, O. (2004. ) Nature 430, 785–789. [PubMed] 9. Johnston, R. J. & Hobert, O. (2003. ) Nature 426, 845–849. [PubMed] 10. Lagos-Quintana, M., Rauhut, R., Yalcin, A., Meyer, J., Lendeckel, W. & Tuschl, T. (2002. ) Curr. Biol. 12, 735–739. [PubMed] 11. Hutvagner, G. & Zamore, P. D. (2002. ) Science 297, 2056–2060. [PubMed] 12. Brennecke, J., Hipfner, D. R., Stark, A., Russell, R. B. & Cohen, S. M. (2003. ) Cell 113, 25–36. [PubMed] 13. Mansfield, J. H., Harfe, B. D., Nissen, R., Obenauer, J., Srineel, J., Chaudhuri, A., Farzan-Kashani, R., Zuker, M., Pasquinelli, A. E., Ruvkun, G., et al. (2004. ) Nat. Genet. 36, 1079–1083. [PubMed] 14. Lee, Y., Jeon, K., Lee, J. T., Kim, S. & Kim, V. N. (2002. ) EMBO J. 21, 4663–4670. [PubMed] 15. Kosman, D., Mizutani, C. M., Lemons, D., Cox, W. G., McGinnis, W. & Bier, E. (2004. ) Science 305, 846. [PubMed] 16. Ronshaugen, M. & Levine, M. (2004. ) Dev. Cell 7, 925–932. [PubMed] 17. Patel, N. H. (1996. ) in A Laboratory Guide to RNA: Isolation, Analysis, and Synthesis, ed. Kreig, P. (Wiley-Liss, New York), pp. 357–370. 18. Abdelilah-Seyfried, S., Chan, Y. M., Zeng, C., Justice, N. J., Younger-Shepherd, S., Sharp, L. E., Barbel, S., Meadows, S. A., Jan, L. Y. & Jan, Y. N. (2000. ) Genetics 155, 733–752. [PubMed] 19. Lai, E. C., Tam, B. & Rubin, G. M. (2005. ) Genes Dev. 19, 1067–1080. [PubMed] 20. Lai, E. C., Tomancak, P., Williams, R. W. & Rubin, G. M. (2003. ) Genome Biol. 4, R42.1–R42.20. [PubMed] 21. Cumberledge, S., Zaratzian, A. & Sakonju, S. (1990. ) Proc. Natl. Acad. Sci. USA 87, 3259–3263. [PubMed] 22. Tomancak, P., Beaton, A., Weiszmann, R., Kwan, E., Shu, S., Lewis, S. E., Richards, S., Ashburner, M., Hartenstein, V., Celniker, S. E. & Rubin, G. M. (2002. ) Genome Biol. 3, research0088. [PubMed] 23. Sempere, L. F., Freemantle, S., Pitha-Rowe, I., Moss, E., Dmitrovsky, E. & Ambros, V. (2004. ) Genome Biol. 5, R13. [PubMed] 24. Kim, J., Krichevsky, A., Grad, Y., Hayes, G. D., Kosik, K. S., Church, G. M. & Ruvkun, G. (2004. ) Proc. Natl. Acad. Sci. USA 101, 360–365. [PubMed] 25. Baskerville, S. & Bartel, D. P. (2005. ) RNA 11, 241–247. [PubMed] 26. Lagos-Quintana, M., Rauhut, R., Lendeckel, W. & Tuschl, T. (2001. ) Science 294, 853–858. [PubMed] 27. Stark, A., Brennecke, J., Russell, R. B. & Cohen, S. M. (2003. ) PLoS Biol. 1, E60. [PubMed] 28. Charroux, B., Angelats, C., Fasano, L., Kerridge, S. & Vola, C. (1999. ) Mol. Cell. Biol. 19, 7846–7856. [PubMed] 29. Miska, E. A., Alvarez-Saavedra, E., Townsend, M., Yoshii, A., Sestan, N., Rakic, P., Constantine-Paton, M. & Horvitz, H. R. (2004. ) Genome Biol. 5, R68. [PubMed] 30. Wienholds, E., Kloosterman, W. P., Miska, E., Alvarez-Saavedra, E., Berezikov, E., de Bruijn, E., Horvitz, H. R., Kauppinen, S. & Plasterk, R. H. (2005. ) Science 309, 310–311. [PubMed] 31. The Flybase Consortium (2003. ) Nucleic Acids Res. 31, 172–175. [PubMed] 32. Grun, D., Wang, Y.-L., Langenberger, D., Gunsalus, K. C. & Rajewsky, N. (2005. ) PLoS Comp. Biol. 1, 0051–0063. 33. Enright, A. J., John, B., Gaul, U., Tuschl, T., Sander, C. & Marks, D. S. (2003. ) Genome Biol. 5, R1. [PubMed] 34. Aravin, A., Lagos-Quintana, M., Yalcin, A., Zavolan, M., Marks, D., Snyder, B., Gaasterland, T., Meyer, J. & Tuschl, T. (2003. ) Dev. Cell 5, 337–350. [PubMed] 35. Leaman, D., Chen, P. Y., Fak, J., Yalcin, A., Pearce, M., Unnerstall, U., Marks, D. S., Sander, C., Tuschl, T. & Gaul, U. (2005. ) Cell 121, 1097–1108. [PubMed] 36. Giraldez, A. J., Cinalli, R. M., Glasner, M. E., Enright, A. J., Thomson, J. M., Baskerville, S., Hammond, S. M., Bartel, D. P. & Schier, A. F. (2005. ) Science 308, 833–838. [PubMed] 37. Bernstein, E., Kim, S. Y., Carmell, M. A., Murchison, E. P., Alcorn, H., Li, M. Z., Mills, A. A., Elledge, S. J., Anderson, K. V. & Hannon, G. J. (2003. ) Nat. Genet. 35, 215–217. [PubMed] 38. Moss, E. G. & Tang, L. (2003. ) Dev. Biol. 258, 432–442. [PubMed] 39. Lim, L. P., Lau, N. C., Garrett-Engele, P., Grimson, A., Schelter, J. M., Castle, J., Bartel, D. P., Linsley, P. S. & Johnson, J. M. (2005. ) Nature 433, 769–773. [PubMed] |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||
Cell. 2004 Jan 23; 116(2):281-97.
[Cell. 2004]Curr Biol. 2003 Dec 2; 13(23):R925-36.
[Curr Biol. 2003]Cell. 2002 Aug 23; 110(4):513-20.
[Cell. 2002]Science. 2004 Jan 2; 303(5654):83-6.
[Science. 2004]Nature. 2004 Nov 11; 432(7014):226-30.
[Nature. 2004]Genes Dev. 2005 Oct 1; 19(19):2343-54.
[Genes Dev. 2005]Nature. 2004 Aug 12; 430(7001):785-9.
[Nature. 2004]Nature. 2003 Dec 18; 426(6968):845-9.
[Nature. 2003]Curr Biol. 2002 Apr 30; 12(9):735-9.
[Curr Biol. 2002]Science. 2002 Sep 20; 297(5589):2056-60.
[Science. 2002]Cell. 2003 Apr 4; 113(1):25-36.
[Cell. 2003]Nat Genet. 2004 Oct; 36(10):1079-83.
[Nat Genet. 2004]EMBO J. 2002 Sep 2; 21(17):4663-70.
[EMBO J. 2002]Science. 2004 Aug 6; 305(5685):846.
[Science. 2004]Dev Cell. 2004 Dec; 7(6):925-32.
[Dev Cell. 2004]Genetics. 2000 Jun; 155(2):733-52.
[Genetics. 2000]Genes Dev. 2005 May 1; 19(9):1067-80.
[Genes Dev. 2005]Science. 2004 Aug 6; 305(5685):846.
[Science. 2004]Nature. 2004 Nov 11; 432(7014):226-30.
[Nature. 2004]Genome Biol. 2003; 4(7):R42.
[Genome Biol. 2003]Proc Natl Acad Sci U S A. 1990 May; 87(9):3259-63.
[Proc Natl Acad Sci U S A. 1990]Nat Genet. 2004 Oct; 36(10):1079-83.
[Nat Genet. 2004]Genome Biol. 2002; 3(12):RESEARCH0088.
[Genome Biol. 2002]Genes Dev. 2005 Oct 1; 19(19):2343-54.
[Genes Dev. 2005]Curr Biol. 2002 Apr 30; 12(9):735-9.
[Curr Biol. 2002]Genome Biol. 2004; 5(3):R13.
[Genome Biol. 2004]Proc Natl Acad Sci U S A. 2004 Jan 6; 101(1):360-5.
[Proc Natl Acad Sci U S A. 2004]Curr Biol. 2002 Apr 30; 12(9):735-9.
[Curr Biol. 2002]RNA. 2005 Mar; 11(3):241-7.
[RNA. 2005]Science. 2001 Oct 26; 294(5543):853-8.
[Science. 2001]Genes Dev. 2005 May 1; 19(9):1067-80.
[Genes Dev. 2005]PLoS Biol. 2003 Dec; 1(3):E60.
[PLoS Biol. 2003]Mol Cell Biol. 1999 Nov; 19(11):7846-56.
[Mol Cell Biol. 1999]Genome Biol. 2004; 5(9):R68.
[Genome Biol. 2004]Science. 2005 Jul 8; 309(5732):310-1.
[Science. 2005]Nucleic Acids Res. 2003 Jan 1; 31(1):172-5.
[Nucleic Acids Res. 2003]Genetics. 2000 Jun; 155(2):733-52.
[Genetics. 2000]Genes Dev. 2005 May 1; 19(9):1067-80.
[Genes Dev. 2005]PLoS Biol. 2003 Dec; 1(3):E60.
[PLoS Biol. 2003]Mol Cell Biol. 1999 Nov; 19(11):7846-56.
[Mol Cell Biol. 1999]PLoS Biol. 2003 Dec; 1(3):E60.
[PLoS Biol. 2003]Genome Biol. 2003; 5(1):R1.
[Genome Biol. 2003]Dev Cell. 2003 Aug; 5(2):337-50.
[Dev Cell. 2003]Cell. 2005 Jul 1; 121(7):1097-108.
[Cell. 2005]Science. 2005 Jul 8; 309(5732):310-1.
[Science. 2005]Genes Dev. 2005 Oct 1; 19(19):2343-54.
[Genes Dev. 2005]Science. 2005 Jul 8; 309(5732):310-1.
[Science. 2005]Science. 2005 May 6; 308(5723):833-8.
[Science. 2005]Dev Cell. 2003 Aug; 5(2):337-50.
[Dev Cell. 2003]Nat Genet. 2003 Nov; 35(3):215-7.
[Nat Genet. 2003]Cell. 2005 Jul 1; 121(7):1097-108.
[Cell. 2005]Cell. 2005 Jul 1; 121(7):1097-108.
[Cell. 2005]Genes Dev. 2005 Oct 1; 19(19):2343-54.
[Genes Dev. 2005]Dev Biol. 2003 Jun 15; 258(2):432-42.
[Dev Biol. 2003]Nature. 2005 Feb 17; 433(7027):769-73.
[Nature. 2005]Nucleic Acids Res. 2003 Jan 1; 31(1):172-5.
[Nucleic Acids Res. 2003]